{
  "ticker": "BXN",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959459",
  "id": "02959459",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250618",
  "time": "0839",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250618/pdf/06kvhn9hgq4q1b.pdf",
  "summary": "- **GMP Compliance Certificates Received**: Bioxyne's subsidiary Breathe Life Sciences (BLS) has obtained GMP compliance certifications under Mutual Recognition Agreements with Australia, Singapore, the Euro Zone, EU, Canada, and the UK.  \n- **Strategic Expansion**: Company emphasizes entry into European and UK markets, positioning for growth in FY2026.  \n- **FY2026 Outlook**: Expects growth driven by Australian expansion and entry into UK/Germany/EU markets. Guidance to be provided in August 2025.  \n\n**Material Impact**: Certifications facilitate global market access, supporting revenue growth and valuation. Expansion plans signal near-term operational scaling.  \n\n*Omitted*: Background on subsidiaries, corporate history, and routine branding details.",
  "usage": {
    "prompt_tokens": 1259,
    "completion_tokens": 153,
    "total_tokens": 1412,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-17T22:48:45.923159"
}